Pfizer
This article was originally published in The Tan Sheet
Executive Summary
President & Chief Operating Officer Henry McKinnell, MD, will succeed William Steere as CEO on Jan. 1, 2001, following Steere's retirement. McKinnell will succeed Steere as chairman beginning in April 2001. Pfizer originally scheduled the succession for June 2001
You may also be interested in...
Pfizer Has Good Patent Position For Smooth McKinnell/Steere Transition
Pfizer has a relatively stable revenue base from its major products to support the two-year senior management transition from William Steere to Henry McKinnell.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands